Literature DB >> 10863546

Neuroprotective antioxidants from marijuana.

A J Hampson1, M Grimaldi, M Lolic, D Wink, R Rosenthal, J Axelrod.   

Abstract

Cannabidiol and other cannabinoids were examined as neuroprotectants in rat cortical neuron cultures exposed to toxic levels of the neurotransmitter, glutamate. The psychotropic cannabinoid receptor agonist delta 9-tetrahydrocannabinol (THC) and cannabidiol, (a non-psychoactive constituent of marijuana), both reduced NMDA, AMPA and kainate receptor mediated neurotoxicities. Neuroprotection was not affected by cannabinoid receptor antagonist, indicating a (cannabinoid) receptor-independent mechanism of action. Glutamate toxicity can be reduced by antioxidants. Using cyclic voltametry and a fenton reaction based system, it was demonstrated that Cannabidiol, THC and other cannabinoids are potent antioxidants. As evidence that cannabinoids can act as an antioxidants in neuronal cultures, cannabidiol was demonstrated to reduce hydroperoxide toxicity in neurons. In a head to head trial of the abilities of various antioxidants to prevent glutamate toxicity, cannabidiol was superior to both alpha-tocopherol and ascorbate in protective capacity. Recent preliminary studies in a rat model of focal cerebral ischemia suggest that cannabidiol may be at least as effective in vivo as seen in these in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863546

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  46 in total

1.  Cannabis is more than simply delta(9)-tetrahydrocannabinol.

Authors:  Ethan B Russo; John M McPartland
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

Review 2.  Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Authors:  Javier Fernández-Ruiz; Onintza Sagredo; M Ruth Pazos; Concepción García; Roger Pertwee; Raphael Mechoulam; José Martínez-Orgado
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.

Authors:  Christeene G Haj; Percy F Sumariwalla; Lumír Hanuš; Natalya M Kogan; Zhana Yektin; Raphael Mechoulam; Mark Feldmann; Ruth Gallily
Journal:  J Pharmacol Exp Ther       Date:  2015-08-13       Impact factor: 4.030

Review 4.  Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Authors:  P Pacher; G Haskó
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

5.  Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

Authors:  G Esposito; C Scuderi; C Savani; L Steardo; D De Filippis; P Cottone; T Iuvone; V Cuomo; L Steardo
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  Phytomedicines in the Treatment of Migraine.

Authors:  Thilinie Rajapakse; William Jeptha Davenport
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 7.  Cannabis use in pregnancy and early life and its consequences: animal models.

Authors:  Miriam Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

8.  Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.

Authors:  Gerry Jager; Maartje M de Win; Hylke K Vervaeke; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal:  Psychopharmacology (Berl)       Date:  2007-05-03       Impact factor: 4.530

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  Neurocognitive correlates of white matter quality in adolescent substance users.

Authors:  Sunita Bava; Joanna Jacobus; Omar Mahmood; Tony T Yang; Susan F Tapert
Journal:  Brain Cogn       Date:  2009-11-22       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.